e-learning
resources
Madrid 2019
Monday, 30.09.2019
Login
Advanced search
e-learning
resources
COVID-19
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
Global Lung Function Initiative
e-learning
Case reports
CME Online
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
VALUE-Dx
Courses and events
New Horizons in The Treatment of Pulmonary Fibrosis
Evening Symposium
Chairs:
A. Wells London (United Kingdom)
Aims:
Organised by Boehringer Ingelheim International GmbH
Welcome and introduction
A. Wells (London, United Kingdom)
The pathogenesis of IPF: what is the latest paradigm?
P. Sime (Rochester, United States of America)
Splitting: the road to precision medicine in IPF?
E. White (Ann Arbor, United States of America)
Questions and answers
No content made available
No content made available
Lumping: are the commonalities among fibrosing ILDs more important than the differences?
V. Cottin (Lyon, France)
How should we approach the treatment of progressive fibrosing ILDs?
K. Brown (Denver, United States of America)
SSc-ILD: are we entering a new chapter in treatment?
T. Maher (St. Albans, United Kingdom)
Questions and answers
No content made available
No content made available
Summary and close
A. Wells (London, United Kingdom)
No content made available
No content made available
COVID-19
Disease Areas
Events
Publications
Guidelines
e-learning
VALUE-Dx
Login